Incidence of Pediatric UTI Decreased in Early Pandemic Period
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 3, 2024 -- The incidence of pediatric urinary tract infection (UTI) decreased during the early prepandemic period, with no increase in disease severity, according to a study published online Jan. 3 in JAMA Network Open.
Danni Liang, M.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues examined the population incidence of UTI in children and examined the changes in UTI diagnoses and measures of UTI severity associated with the COVID-19 pandemic in a retrospective observational cohort study. The cohort included 13,221,117 enrollees aged 0 to 17 years (51.0 percent male).
The researchers found that the mean incidence of UTI diagnoses was 1.300 UTIs per 100 patient-years. The incidence of UTI was 0.86, 1.58, 1.24, and 1.37 per 100 patient-years at age 0 to 1 years, 2 to 5 years, 6 to 11 years, and 12 to 17 years, respectively; incidence was higher among girls than boys (2.48 versus 0.18 per 100 patient-years). UTIs decreased in the early pandemic compared with prepandemic trends (−33.1 percent for all children; −52.1 percent for infants aged 60 days or younger). All measures of UTI severity decreased or remained stable. After the first three months of the pandemic, the incidence of UTI returned to near prepandemic rates.
"Our findings may inform discussion around the overdiagnosis and/or misdiagnosis of UTI, optimal diagnostic strategies, and definitions for pediatric UTI," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-04 02:15
Read more
- World War II Data Shows Impact of Sugar on Kids' Health
- Even at Low Levels, Arsenic in Drinking Water Could Raise Heart Risks
- Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
- Urban Green Space May Protect Against Heat-Related Health Risks
- FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- Healthy Eating Index 2015 Score Linked to Overactive Bladder
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions